发明名称 |
Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment |
摘要 |
A method for determining those patients suffering from mild cognitive impairment (MCI) who have a likelihood of progressing to Alzheimer's disease (AD) is disclosed. The method involves directly detecting the presence of a biochemical marker, specifically human glutamine synthetase, in bodily fluid, preferably blood or a blood product. The detection is by an immunoassay incorporating an antibody specific to human glutamine synthetase. In addition, a method for distinguishing between AD and non-AD dementia is disclosed.
|
申请公布号 |
NZ538669(A) |
申请公布日期 |
2007.01.26 |
申请号 |
NZ20030538669 |
申请日期 |
2003.09.16 |
申请人 |
SYN.X PHARMA, INC. |
发明人 |
JACKOWSKI, GEORGE;TAKAHASHI, MIYOKO |
分类号 |
G01N33/53;C07K16/40;C12N5/10;C12P21/08;G01N33/48;G01N33/566;G01N33/573;G01N33/577;G01N33/68;(IPC1-7):G01N33/68 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|